Tags:CareDesignDevelopmentDrugPersonalPlatformProductPublicScienceTechnology
Epizyme is a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer
Location: United States, Massachusetts, Cambridge
Member count: 201-500
Total raised: $496M
Founded date: 2007

Investors 6

Funding Rounds 5

DateSeriesAmountInvestorsDeal News
06.11.2020-$150M-biospace.c...
05.11.2019-$270M-finsmes.co...
22.04.2014-$4M-baycitycap...
08.12.2009Series B$40MNew Enterp...finsmes.co...
07.10.2009Series B$32M-finsmes.co...

Mentions in press and media 15

DateTitleDescriptionCategoryAuthorSource
19.12.2019FDA panel ...Shares of Epizyme rose 35.6% o...--medcitynew...
05.11.2019Epizyme Ra...Epizyme, Inc. (Nasdaq: EPZM), ...USA-finsmes.co...
25.07.2019FDA to mak...Epizyme’s shares fell nearly 1...--medcitynew...
12.03.2015Epizyme Re...CAMBRIDGE, Mass., Mar 12, 2015...--baycitycap...
22.04.2014Epizyme Ac...Cambridge, MA — Epizyme, Inc. ...--baycitycap...
30.10.2013Which vent...I won’t get into Aratana Thera...--medcitynew...
26.04.2012Celgene su...Celgene also has a phase 3 tri...--medcitynew...
08.12.2009Epizyme Cl...Epizyme, Inc., a Cambridge, MA...Start Up ...-finsmes.co...
07.10.2009USA, Epizy...Cambridge, MA-based Epizyme, I...Start Up ...-finsmes.co...
-FDA to mak...The Food and Drug Administrati...--medcitynew...
Show more